With the acquisition of Mundo Animal the company adds a wide range of products to its portfolio. It is positioned as the largest producer of veterinary vaccines in Latin America.
Biogenesis Bagó, a global biotechnology company specialized in the development, production and marketing of products and services aimed at animal health, productivity and well-being, announced the acquisition of Mundo Animal, a company with more than 40 years of experience in the animal market. Brazilian pets.
According to consulted sources, the firm would have paid around US$20 million for this leading firm in the pet segment.
“The integration of Mundo Animal will allow us to have a more complete portfolio and is an opportunity to continue creating opportunities together. “His track record in the Brazilian market and his passion for providing quality products are aligned with our commitment to contribute to improving the well-being of our life partners,” he said. Carol Galli, veterinarian and director of the Pets segment of Biogenesis Bagó.
Mundo Animal has a manufacturing and R&D site in Pindamonhangaba, state of São Paulo, Brazil, where nutrition, medicine and hygiene supplements for pets, recognized for their quality, are developed and produced. From this integration, these products will be complemented with Biogenesis Bagó’s current portfolio to give rise to a global portfolio of more than 200 solutions for this segment.
“As part of our diversification strategy in territories and species, at Biogenesis Bagó we have been betting on continued growth in the companion animal segment. The acquisition of Mundo Animal, added to the decisions taken in recent years, are a fundamental step to comply with our strategic plan,” commented Esteban Turic, CEO of Biogenesis Bagó.
Brazil is the third largest market in the world for companion animals. The acquisition also adds to the technology transfer agreement that Biogenesis Bagó signed with the Paraná Institute of Technology (TECPAR) for the production of anti-rabies vaccines in Brazil and the recent acquisition of Campo Largo, a manufacturing site where it will produce more than 10 million doses of vaccines for companion animals. The sum of these milestones positions Biogenesis Bagó as the largest producer of veterinary vaccines in Latin America.
Source: Ambito
I am a 24-year-old writer and journalist who has been working in the news industry for the past two years. I write primarily about market news, so if you’re looking for insights into what’s going on in the stock market or economic indicators, you’ve come to the right place. I also dabble in writing articles on lifestyle trends and pop culture news.
